Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pegram

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Oncology|May 3, 2011
Thalidomide and chemotherapy combinationM Nguyen, C Tran, S Barsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancerG Konecny, M Untch, A Pihan, et al.
Gynecologic Oncology|April 29, 2000
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancerG Konecny, C Crohns, M Pegram, et al.
Leukemia|September 1, 1987
Lineage specificity of rearrangement and expression of genes encoding the T cell receptor-T3 complex and immunoglobulin heavy chain in leukemiaA J Furley, L C Chan, S Mizutani, et al.
Journal of the American College of Emergency Physicians Open|October 1, 2020
Accidental hypothermic cardiac arrest and extracorporeal membrane oxygenation: a case reportP Daniel Patterson, Taylor C Hupfeld, Nia Forbes, et al.
Breast Cancer Research and Treatment|September 20, 2001
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samplesG Konecny, M Untch, D Slamon, et al.
Oncogene|May 18, 1999
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersM Pegram, S Hsu, G Lewis, et al.
Breast Cancer Research and Treatment|January 5, 2002
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancerG Konecny, M Fritz, M Untch, et al.
Biochemistry|September 18, 2009
Interactions of the osmolyte glycine betaine with molecular surfaces in water: thermodynamics, structural interpretation, and prediction of m-valuesMichael W Capp, Laurel M Pegram, Ruth M Saecker, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2Jake W Anderson, David Vaisar, David N Jones, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Oncology|May 3, 2011
Thalidomide and chemotherapy combinationM Nguyen, C Tran, S Barsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancerG Konecny, M Untch, A Pihan, et al.
Gynecologic Oncology|April 29, 2000
Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancerG Konecny, C Crohns, M Pegram, et al.
Leukemia|September 1, 1987
Lineage specificity of rearrangement and expression of genes encoding the T cell receptor-T3 complex and immunoglobulin heavy chain in leukemiaA J Furley, L C Chan, S Mizutani, et al.
Journal of the American College of Emergency Physicians Open|October 1, 2020
Accidental hypothermic cardiac arrest and extracorporeal membrane oxygenation: a case reportP Daniel Patterson, Taylor C Hupfeld, Nia Forbes, et al.
Breast Cancer Research and Treatment|September 20, 2001
Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samplesG Konecny, M Untch, D Slamon, et al.
Oncogene|May 18, 1999
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersM Pegram, S Hsu, G Lewis, et al.
Breast Cancer Research and Treatment|January 5, 2002
HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancerG Konecny, M Fritz, M Untch, et al.
Biochemistry|September 18, 2009
Interactions of the osmolyte glycine betaine with molecular surfaces in water: thermodynamics, structural interpretation, and prediction of m-valuesMichael W Capp, Laurel M Pegram, Ruth M Saecker, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Conformation Selection by ATP-competitive Inhibitors and Allosteric Communication in ERK2Jake W Anderson, David Vaisar, David N Jones, et al.
Pageof 4